Study points to challenges, hopes of helping vulnerable patients avoid stroke

A new study demonstrates the importance and challenge of treating people at high risk of stroke. However, it did not find that the drug ticagrelor was better than aspirin, the current standard, in reducing the risk of stroke, heart attack, or death in patients presenting with transient ischemic attack or minor stroke